Skip to main content

Table 4 MS prevalence by BMI, gender and clinical lipodystrophy according to ATPIII criteria and IDF

From: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

 

Men

Women

 

Without CL

With CL

Without CL

With CL

ATPIII criteria

Classes of BMI

[kg/m2; (n (%)]

    

< 25

14 (30.4%)

41 (48.8%)

3 (12.5%)

11 (44.0%)

≥25 < 30

19 (41.3%)

33 (39.3%)

9 (37.5%)

10 (40.0%)

≥30

13 (28.3%)

10 (11.9%)

12 (50.0%)

4 (16.0%)

p value

0.002

< 0.001

0.012

0.008

IDF criteria

< 25

4 (11.1%)

11 (21.2%)

5 (18.5%)

16 (48.5%)

≥25 < 30

18 (50.0%)

32 (61.5%)

10 (37.0%)

13 (39.4%)

≥30

14 (38.9%)

9 (17.3%)

12 (44.4%)

4 (12.1%)

p value

< 0.001

< 0.001

0.084

0.012

  1. Note - CL = Clinical lipodystrophy; MS = Metabolic syndrome; ATPIII = Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults; IDF = International Diabetes Federation; BMI = body mass in
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us